Non-Interventional Study of Zoladex in Endometriosis

A Non-interventional Study of Postoperative Treatment With Goserelin Acetate (Zoladex) in Moderate to Severe Endometriosis Patient

This is a prospective, open label NIS, which is to assess the efficacy of Zoladex in adjuvant setting after operation in moderate to severe endometriosis patients.

Inclusion Criteria:

• Advanced endometriosis confirmed histologically (r-AFS score III-IV) with conservative laparoscopy or laparotomy.
• Patient who has the indication of Zoladex and has been prescribed Zoladex according to physician's judgement, irrespective of the inclusion in the study.
• Patient has been already prescribed Zoladex within 1 month after operation.

Exclusion Criteria:

• Have used hormone treatment prior to 3 months of recruitment.
• Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site).
• Previous enrolment in the present study.